利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

75 条记录 (耗时 0.046 秒)

    COMMUNICATION BETWEEN IMPLANTABLE MEDICAL DEVICES
    2.
    发明申请
    COMMUNICATION BETWEEN IMPLANTABLE MEDICAL DEVICES 审中-公开
    可植入医疗器械之间的通讯

    公开(公告)号：US20100114209A1

    公开(公告)日：2010-05-06

    申请号：US12363215

    申请日：2009-01-30

    申请人： Paul G. Krause ,  William T. Donofrio ,  Gerald P. Arne ,  John E. Burnes ,  David J. Peichel ,  Xiaohong Zhou

    发明人： Paul G. Krause ,  William T. Donofrio ,  Gerald P. Arne ,  John E. Burnes ,  David J. Peichel ,  Xiaohong Zhou

    IPC分类号： A61N1/08

    CPC分类号： A61N1/37288 ,  A61N1/36082 ,  A61N1/362 ,  A61N1/3706 ,  A61N1/37217 ,  A61N1/3727

    摘要： A first implantable medical device (IMD) implanted within a patient may communicate with a second IMD implanted within the patient by encoding information in an electrical stimulation signal. The delivery of the electrical stimulation signal may provide therapeutic benefits to the patient. The second IMD may sense the electrical stimulation signal, which may be presented as an artifact in a sensed cardiac signal, and process the sensed signal to retrieve the encoded information. The second IMD may modify its operation based on the received therapy information. Crosstalk between the first and second IMDs may be reduced using various techniques described herein. For example, the first IMD may generate the electrical stimulation signal to include a spread spectrum energy distribution or a predetermined signal signature. The second IMD may effectively remove a least some of the signal artifact in a sensed cardiac signal based on the predetermined signal signature.

    摘要翻译： 植入在患者体内的第一可植入医疗装置（IMD）可以通过对电刺激信号中的信息进行编码来与植入患者内的第二IMD进行通信。 电刺激信号的传递可以为患者提供治疗益处。 第二IMD可以感测电刺激信号，其可以被呈现为感测到的心脏信号中的伪像，并且处理感测到的信号以检索经编码的信息。 第二IMD可以基于接收到的治疗信息修改其操作。 可以使用本文所述的各种技术来减少第一和第二IMD之间的串扰。 例如，第一IMD可以产生电刺激信号以包括扩频能量分布或预定信号特征。 基于预定的信号签名，第二IMD可以有效地去除感测到的心脏信号中的至少一些信号伪像。

    CLOSED-LOOP NEUROSTIMULATION TO TREAT PULMONARY EDEMA
    7.
    发明申请
    CLOSED-LOOP NEUROSTIMULATION TO TREAT PULMONARY EDEMA 审中-公开
    闭合环境神经病学治疗肺动脉高压

    公开(公告)号：US20100198308A1

    公开(公告)日：2010-08-05

    申请号：US12696914

    申请日：2010-01-29

    申请人： Xiaohong Zhou ,  William T. Donofrio ,  Paul G. Krause ,  John E. Burnes

    发明人： Xiaohong Zhou ,  William T. Donofrio ,  Paul G. Krause ,  John E. Burnes

    IPC分类号： A61N1/36

    CPC分类号： A61N1/3601 ,  A61N1/36135 ,  A61N1/36521 ,  A61N1/36564 ,  A61N1/36571 ,  A61N1/36578 ,  A61N1/36592

    摘要： Neurostimulation to mitigate lung wetness is delivered to a patient based on a sensed parameter indicative of lung wetness. The neurostimulation is configured to at least one of increase parasympathetic activity or decrease sympathetic activity within the patient. In some examples, a patient response to the neurostimulation therapy may be detected to modify the neurostimulation therapy. The patient response may include, for example, changes in the contractility of a heart of the patient, changes in the heart rate, heart rate variability or blood pressure of the patient, changes in a bladder size of the patient, changes in bladder functional activity of the patient, changes in urine flow, changes in lung function, changes in lung composition, or changes in the nerve activity of the patient.

    摘要翻译： 基于指示肺湿度的感测参数将减轻肺湿润的神经刺激递送给患者。 神经刺激被配置成在患者体内增加副交感神经活动或减少交感神经活动中的至少一种。 在一些实例中，可以检测患者对神经刺激疗法的反应以修饰神经刺激疗法。 患者反应可以包括例如患者的心脏的收缩性变化，心率的改变，患者的心率变异性或血压，患者的膀胱尺寸的变化，膀胱功能活动的变化 的患者，尿流量的变化，肺功能的变化，肺组成的变化或患者的神经活动的变化。

    Therapy module crosstalk mitigation
    10.
    发明授权
    Therapy module crosstalk mitigation 有权
    治疗模块串扰减轻

    公开(公告)号：US08301263B2

    公开(公告)日：2012-10-30

    申请号：US12363180

    申请日：2009-01-30

    申请人： William T. Donofrio ,  Paul G. Krause ,  Gerald P. Arne ,  John E. Burnes ,  David J. Peichel ,  Xiaohong Zhou

    发明人： William T. Donofrio ,  Paul G. Krause ,  Gerald P. Arne ,  John E. Burnes ,  David J. Peichel ,  Xiaohong Zhou

    IPC分类号： A61N1/00

    CPC分类号： A61N1/37288 ,  A61N1/36114

    摘要： A first implantable medical device (IMD) implanted within a patient may communicate with a second IMD implanted within the patient by encoding information in an electrical stimulation signal. The delivery of the electrical stimulation signal may provide therapeutic benefits to the patient. The second IMD may sense the electrical stimulation signal, which may be presented as an artifact in a sensed cardiac signal, and process the sensed signal to retrieve the encoded information. The second IMD may modify its operation based on the received therapy information. Crosstalk between the first and second IMDs may be reduced using various techniques described herein. For example, the first IMD may generate the electrical stimulation signal to include a spread spectrum energy distribution or a predetermined signal signature. The second IMD may effectively remove a least some of the signal artifact in a sensed cardiac signal based on the predetermined signal signature.

    摘要翻译： 植入在患者体内的第一可植入医疗装置（IMD）可以通过对电刺激信号中的信息进行编码来与植入患者内的第二IMD进行通信。 电刺激信号的传递可以为患者提供治疗益处。 第二IMD可以感测电刺激信号，其可以被呈现为感测到的心脏信号中的伪像，并且处理感测到的信号以检索经编码的信息。 第二IMD可以基于接收到的治疗信息修改其操作。 可以使用本文所述的各种技术来减少第一和第二IMD之间的串扰。 例如，第一IMD可以产生电刺激信号以包括扩频能量分布或预定信号特征。 基于预定的信号签名，第二IMD可以有效地去除感测到的心脏信号中的至少一些信号伪像。